Method for the treatment of disease associated with angiogenesis

The present invention relates to a method of treating disease associated with angiogenesis using an N-Methyl-D-aspartate receptor (NMDA) antagonist. More specifically, it concerns use of an NMDA receptor antagonist, for the treatment of disease associated with angiogenesis such as tumor angiogenesis, ocular neovascular disease, Age-related macular degeneration (AMD).

Keywords: NMDAR antagonist - Target - Angiogenesis
Patent Application number: European Procedure (Patents) (EPA) - 30 Nov. 2015 - 15 306 894.5
Inventors:
BRU-MERCIER GillesDUMAS Sébastien
Publications:
null

Reference:

BIO13165-T1

    Business Developper
    contact
    Aymeric Empereur
    Business Developer
    Patent filling date: 30-11-2015
    Rare disease: No
    Second indication: Yes

    You might also be interested in